Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

May 6, 2020May 6, 2020

Study: Sugar Molecules in Autoantibodies May Help CAD Diagnosis

News

The autoantibodies found in people with cold agglutinin disease (CAD) carry high levels of sugar molecules, which may help distinguish them from those with related disorders, a study has ... Read more

March 10, 2020March 10, 2020

Pediatric Rare Disease Therapies Increase, But Most Repurposed, Study Finds

News

The number of treatments for children with rare diseases has grown over the past decade, according to a new study. However, despite the increase, nearly 7,000 rare diseases are still ... Read more

February 25, 2020February 25, 2020

AIHA Found Linked to Hepatitis E Infection in Rare Case Study

News

The rare case of a man infected with the hepatitis E virus who developed autoimmune hemolytic anemia was described in a study that also highlighted the potential for underdiagnosing ... Read more

January 28, 2020January 28, 2020

Undiagnosed AIHA Patients May Be Given Wrong Blood Type During Transfusions, With Life-threatening Consequences, Case Study Says

News

The wrong blood type may be given to people with undiagnosed autoimmune hemolytic anemia (AIHA), which can lead to them receiving blood transfusions from mismatched blood donors, a case ... Read more

January 14, 2020January 15, 2020

Blood Transfusions Safe, Efficient for Treating Hospitalized AIHA Patients, Study Suggests

News

Treatment with blood transfusions is safe and efficient for treating hospitalized autoimmune hemolytic anemia (AIHA) patients, a large observational study suggests. This conclusion held true even when using ... Read more

December 17, 2019December 17, 2019

Nearly $200,000 Awarded to Cold Agglutinin Disease Foundation, Other Rare Disease Organizations

News

The Cold Agglutinin Disease Foundation is among 20 rare disease organizations receiving funding under Global Genes‘ 2020 RARE Patient Impact Grant Program. Now in its fifth year, the 2020 grant ... Read more

November 5, 2019November 5, 2019

Risk of Blood Clots Higher in CAD Patients Than General Population, Study Concludes

News

Cold agglutinin disease (CAD) patients have an increased risk of developing blood clots compared to the general population, a retrospective Danish study shows. The findings of the study, “Occurrence, thromboembolic ... Read more

October 21, 2019October 21, 2019

Arzerra a Potential Alternative to Rituxan for Patients with AIHA and Lupus, Case Report Suggests

News

Arzerra (ofatumumab) may be a promising alternative for the treatment of autoimmune hemolytic anemia (AIHA) in patients who also have systemic lupus erythematosus (SLE) and develop reactions to Rituxan ... Read more

October 7, 2019October 7, 2019

Earlier Meningitis Vaccine Booster May be Necessary for CAD Patients on Anti-complement Therapy, Study Suggests

News

To lower the risk of meningitis infection in patients with cold agglutinin disease (CAD) treated with Soliris (eculizumab), a booster given shortly after the first vaccination may be required, ... Read more

August 26, 2019August 26, 2019

Study Reports Rare Case of CAD Arising After Cryoablation Therapy

News

Researchers recently reported the rare case of a 69-year-old Japanese man with paroxysmal atrial fribrillation (PAF) — occasional periods of an irregular, very fast heart rate — who developed ... Read more

Pin It on Pinterest